Literature DB >> 10713055

A deficiency of microsomal triglyceride transfer protein reduces apolipoprotein B secretion.

G K Leung1, M M Véniant, S K Kim, C H Zlot, M Raabe, J Björkegren, R A Neese, M K Hellerstein, S G Young.   

Abstract

Microsomal triglyceride transfer protein (MTP) transfers lipids to apolipoprotein B (apoB) within the endoplasmic reticulum, a process that involves direct interactions between apoB and the large subunit of MTP. Recent studies with heterozygous MTP knockout mice have suggested that half-normal levels of MTP in the liver reduce apoB secretion. We hypothesized that reduced apoB secretion in the setting of half-normal MTP levels might be caused by a reduced MTP:apoB ratio in the endoplasmic reticulum, which would reduce the number of apoB-MTP interactions. If this hypothesis were true, half-normal levels of MTP might have little impact on lipoprotein secretion in the setting of half-normal levels of apoB synthesis (since the ratio of MTP to apoB would not be abnormally low) and might cause an exaggerated reduction in lipoprotein secretion in the setting of apoB overexpression (since the MTP:apoB ratio would be even lower). To test this hypothesis, we examined the effects of heterozygous MTP deficiency on apoB metabolism in the setting of normal levels of apoB synthesis, half-normal levels of apoB synthesis (heterozygous Apob deficiency), and increased levels of apoB synthesis (transgenic overexpression of human apoB). Contrary to our expectations, half-normal levels of MTP reduced the plasma apoB100 levels to the same extent ( approximately 25-35%) at each level of apoB synthesis. In addition, apoB secretion from primary hepatocytes was reduced to a comparable extent at each level of apoB synthesis. Thus, these results indicate that the concentration of MTP within the endoplasmic reticulum rather than the MTP:apoB ratio is the critical determinant of lipoprotein secretion. Finally, we found that heterozygosity for an apoB knockout mutation lowered plasma apoB100 levels more than heterozygosity for an MTP knockout allele. Consistent with that result, hepatic triglyceride accumulation was greater in heterozygous apoB knockout mice than in heterozygous MTP knockout mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713055     DOI: 10.1074/jbc.275.11.7515

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Nocturnin regulates circadian trafficking of dietary lipid in intestinal enterocytes.

Authors:  Nicholas Douris; Shihoko Kojima; Xiaoyue Pan; Alexandra F Lerch-Gaggl; Son Q Duong; M Mahmood Hussain; Carla B Green
Journal:  Curr Biol       Date:  2011-08-04       Impact factor: 10.834

2.  Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis.

Authors:  G P Hayhurst; Y H Lee; G Lambert; J M Ward; F J Gonzalez
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

3.  Comparison of the pharmacological profiles of murine antisense oligonucleotides targeting apolipoprotein B and microsomal triglyceride transfer protein.

Authors:  Richard G Lee; Wuxia Fu; Mark J Graham; Adam E Mullick; Donna Sipe; Danielle Gattis; Thomas A Bell; Sheri Booten; Rosanne M Crooke
Journal:  J Lipid Res       Date:  2012-12-06       Impact factor: 5.922

4.  In vivo role of the HNF4alpha AF-1 activation domain revealed by exon swapping.

Authors:  Nadège Briançon; Mary C Weiss
Journal:  EMBO J       Date:  2006-02-23       Impact factor: 11.598

5.  Nonalcoholic steatohepatitis (NASH) in ob/ob mice treated with yo jyo hen shi ko (YHK): effects on peroxisome proliferator-activated receptors (PPARs) and microsomal triglyceride transfer protein (MTP).

Authors:  José Tadeu Stefano; Claudia Pinto Marques Souza de Oliveira; Maria Lúcia Corrêa-Giannella; Vicência Mara Rodrigues de Lima; Sandra Valéria de Sá; Ellen Pierre de Oliveira; Evandro Sobroza de Mello; Daniel Giannella-Neto; Venâncio Avancini Ferreira Alves; Flair José Carrilho
Journal:  Dig Dis Sci       Date:  2007-03-30       Impact factor: 3.199

6.  FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice.

Authors:  Adama Kamagate; Shen Qu; German Perdomo; Dongming Su; Dae Hyun Kim; Sandra Slusher; Marcia Meseck; H Henry Dong
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

7.  Overindulgence and metabolic syndrome: is FoxO1 a missing link?

Authors:  Janet D Sparks; Charles E Sparks
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

Review 8.  FoxO1 integrates insulin signaling to VLDL production.

Authors:  Adama Kamagate; H Henry Dong
Journal:  Cell Cycle       Date:  2008-10-27       Impact factor: 4.534

9.  ApoB100 is required for increased VLDL-triglyceride secretion by microsomal triglyceride transfer protein in ob/ob mice.

Authors:  Zhouji Chen; Elizabeth P Newberry; Jin Y Norris; Yan Xie; Jianyang Luo; Susan M Kennedy; Nicholas O Davidson
Journal:  J Lipid Res       Date:  2008-06-02       Impact factor: 5.922

10.  IRE1beta inhibits chylomicron production by selectively degrading MTP mRNA.

Authors:  Jahangir Iqbal; Kezhi Dai; Tracie Seimon; Rivka Jungreis; Miho Oyadomari; George Kuriakose; David Ron; Ira Tabas; M Mahmood Hussain
Journal:  Cell Metab       Date:  2008-05       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.